Epigenetics Underpinning the Regulation of the CXC (ELR+) Chemokines in Non-Small Cell Lung Cancer

Background Angiogenesis may play a role in the pathogenesis of Non-Small Cell Lung cancer (NSCLC). The CXC (ELR+) chemokine family are powerful promoters of the angiogenic response. Methods The expression of the CXC (ELR+) family members (CXCL1-3/GROα-γ, CXCL8/IL-8, CXCR1/2) was examined in a series of resected fresh frozen NSCLC tumours. Additionally, the expression and epigenetic regulation of these chemokines was examined in normal bronchial epithelial and NSCLC cell lines. Results Overall, expression of the chemokine ligands (CXCL1, 2, 8) and their receptors (CXCR1/2) were down regulated in tumour samples compared with normal, with the exception of CXCL3. CXCL8 and CXCR1/2 were found to be epigenetically regulated by histone post-translational modifications. Recombinant CXCL8 did not stimulate cell growth in either a normal bronchial epithelial or a squamous carcinoma cell line (SKMES-1). However, an increase was observed at 72 hours post treatment in an adenocarcinoma cell line. Conclusions CXC (ELR+) chemokines are dysregulated in NSCLC. The balance of these chemokines may be critical in the tumour microenvironment and requires further elucidation. It remains to be seen if epigenetic targeting of these pathways is a viable therapeutic option in lung cancer treatment.

[1]  A. Richmond,et al.  Chemokines and chemokine receptors: new insights into cancer-related inflammation. , 2010, Trends in molecular medicine.

[2]  S. Zöchbauer-Müller,et al.  Lung cancer: From single-gene methylation to methylome profiling , 2010, Cancer and Metastasis Reviews.

[3]  P. Bradding,et al.  Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer , 2010, BMC Cancer.

[4]  Larry Norton,et al.  Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.

[5]  J. Lee,et al.  Snail Promotes CXCR2 LigandDependent Tumor Progression in NonSmall Cell Lung Carcinoma , 2009, Clinical Cancer Research.

[6]  D. Trisciuoglio,et al.  Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. , 2009, European journal of cancer.

[7]  K. O'Byrne,et al.  Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy , 2009, Journal of cellular and molecular medicine.

[8]  A. Morillon,et al.  Histone H3 Lysine 4 di-methylation: A novel mark for transcriptional fidelity? , 2009, Epigenetics.

[9]  J. Gil,et al.  A role for CXCR2 in senescence, but what about in cancer? , 2009, Cancer research.

[10]  Rakesh K. Singh,et al.  Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis. , 2009, Cancer research.

[11]  Patrick G. Shaw,et al.  Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells , 2009, Breast Cancer Research and Treatment.

[12]  C. Jorgensen,et al.  Interleukin-8 Expression Is Regulated by Histone Deacetylases through the Nuclear Factor-κB Pathway in Breast Cancer , 2008, Molecular Pharmacology.

[13]  Jonathan Melamed,et al.  Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence , 2008, Cell.

[14]  C. Englert,et al.  TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels , 2008, Nucleic acids research.

[15]  C. Bokemeyer,et al.  The Local Cytokine and Chemokine Milieu within Malignant Effusions , 2008, Tumor Biology.

[16]  Ann Richmond,et al.  Role of chemokines in tumor growth. , 2007, Cancer letters.

[17]  R. Strieter,et al.  Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. , 2007, Cancer research.

[18]  Leah E. Mechanic,et al.  Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. , 2007, Journal of the National Cancer Institute.

[19]  D. Gingras,et al.  Membrane-Type 1 Matrix Metalloproteinase Stimulates Cell Migration through Epidermal Growth Factor Receptor Transactivation , 2007, Molecular Cancer Research.

[20]  F. Luppia,et al.  Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation , 2007 .

[21]  Julia L. Wilson,et al.  The chemokine network: a target in cancer biology? , 2006, Advanced drug delivery reviews.

[22]  H. Friess,et al.  Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. , 2006, Cancer letters.

[23]  D. Arenberg.  Chemokines in the biology of lung cancer. , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  M. Burdick,et al.  CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.

[25]  R. Figlin,et al.  The Role of CXCR2/CXCR2 Ligand Biological Axis in Renal Cell Carcinoma1 , 2005, The Journal of Immunology.

[26]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[27]  J. Pollack,et al.  Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins , 2004, Cancer Research.

[28]  M. Burdick,et al.  CXC Chemokines: Angiogenesis, Immunoangiostasis, and Metastases in Lung Cancer , 2004, Annals of the New York Academy of Sciences.

[29]  P. Woll,et al.  Interleukin-8/CXCL8 is a growth factor for human lung cancer cells , 2004, British Journal of Cancer.

[30]  F. Balkwill.  Cancer and the chemokine network , 2004, Nature Reviews Cancer.

[31]  M. Burdick,et al.  Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis , 2004, BMC Cancer.

[32]  M. Burdick,et al.  Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer1 , 2004, The Journal of Immunology.

[33]  W. MacNee,et al.  Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[34]  B. Milleron,et al.  Upregulation of bronchioloalveolar carcinoma-derived C-X-C chemokines by tumor infiltrating inflammatory cells , 2003, Inflammation Research.

[35]  Erika Martinelli,et al.  Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: relationship with prognosis. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[36]  Akira Yamauchi,et al.  The intratumoral expression of vascular endothelial growth factor and interleukin‐8 associated with angiogenesis in nonsmall cell lung carcinoma patients , 2001, Cancer.

[37]  P. Murphy,et al.  Chemokines and the molecular basis of cancer metastasis. , 2001, The New England journal of medicine.

[38]  M. Burdick,et al.  The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity1 , 2000, The Journal of Immunology.

[39]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[40]  M. Shipp,et al.  The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast cocultures. , 2000, Cancer research.

[41]  K J O'Byrne,et al.  The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. , 2000, European journal of cancer.

[42]  R. Hertzberg,et al.  Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration* , 1998, The Journal of Biological Chemistry.

[43]  R. Strieter,et al.  The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer. , 1999, Journal of leukocyte biology.

[44]  M. Burdick,et al.  Enhanced tumor‐forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth‐regulated cytokine β and γ proteins , 1997 .

[45]  P. Musiani,et al.  Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors. , 1997, American journal of respiratory and critical care medicine.

[46]  R. Strieter,et al.  Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. , 1997, International journal of cancer.

[47]  M. Burdick,et al.  Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. , 1996, The Journal of clinical investigation.

[48]  S. Dubinett,et al.  Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.